@article{JTD21165,
author = {You-Cai Zhu and Wen-Xian Wang and Chun-Wei Xu and Qing-He Tan and Jian-Ying Li and Wu Zhuang and Zheng-Bo Song and Kai-Qi Du and Gang Chen and Tang-Feng Lv and Yong Song},
title = {Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {5},
year = {2018},
keywords = {},
abstract = {Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related morbidity and mortality worldwide (1). Epidermal growth factor receptor (EGFR) mutations, as driver oncogenes, were first identified in NSCLC in 2004 (2).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/21165}
}